Significantly improve quality of patients' lives through development of  safe and effective endocannabinoid-based therapeutics.


To be the leaders in need-driven endocannabinoid system-based prescription medication development.


To develop proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms.

Our Focus

Medipure Pharmaceuticals is a biopharmaceutical company conducting pioneering research in prescription pharmaceuticals. We are specifically focused on developing and marketing these propriety therapeutics for targeted diseases.

  • Pain Management
  • Affective disorders
  • Nausea and appetite
  • Palliative care
  • Oncology
  • Arthritis
  • Dermatology